Literature DB >> 8586829

Polymorphisms within the atrial natriuretic peptide gene in essential hypertension.

D R Rutledge1, Y Sun, E A Ross.   

Abstract

OBJECTIVE: To investigate polymorphisms in the atrial natriuretic peptide gene of African Americans at intron two (Hpall) and exon three (Scal).
RESULTS: The allele frequency of the Hpall mutation was 25% in the hypertensive group (n =60) compared with only 3.4% in normotensive individuals (n = 44, P < 0.0001). The genotype heterozygote for the present mutation was much more common among those with hypertension (50 versus 6.8%, P < 0.0001). The groups were no different for the Scal site alone, although the two mutations were present together more often in the hypertensive group. The Hpall mutation was associated with hypertension in this typically salt-sensitive population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586829     DOI: 10.1097/00004872-199509000-00003

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  16 in total

Review 1.  Cardiac genes and gene databases for cardiovascular disease genetics.

Authors:  K T Tan; A Dempsey; C C Liew
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

2.  Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia.

Authors:  George V Z Dedoussis; Sandy Maumus; John Skoumas; Despoina M Choumerianou; Christos Pitsavos; Christodoulos Stefanadis; Sophie Visvikis-Siest
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 3.  Natriuretic Peptides and Cardiometabolic Health.

Authors:  Deepak K Gupta; Thomas J Wang
Journal:  Circ J       Date:  2015-06-23       Impact factor: 2.993

4.  Genetic polymorphisms and endothelial dysfunction in patients with essential hypertension: a cross-sectional case-control study.

Authors:  S Demirel; V Akkaya; N Cine; H Oflaz; E Yekeler; S Ozturk; T J Cleophas; F Fici
Journal:  Neth Heart J       Date:  2005-04       Impact factor: 2.380

5.  Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice.

Authors:  S Jeson Sangaralingham; M Yat Tse; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2007-08-23       Impact factor: 3.396

6.  Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension.

Authors:  Iuliia Polina; Mark Domondon; Rebecca Fox; Anastasia V Sudarikova; Miguel Troncoso; Valeriia Y Vasileva; Yuliia Kashyrina; Monika Beck Gooz; Ryan S Schibalski; Kristine Y DeLeon-Pennell; Wayne R Fitzgibbon; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-28

7.  Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study.

Authors:  Valentina Cannone; Brenda K Huntley; Timothy M Olson; Denise M Heublein; Christopher G Scott; Kent R Bailey; Margaret M Redfield; Richard J Rodeheffer; John C Burnett
Journal:  Hypertension       Date:  2013-09-16       Impact factor: 10.190

Review 8.  A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae.

Authors:  Amy I Lynch; Steven A Claas; Donna K Arnett
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

9.  Alternative splicing of the guanylyl cyclase-A receptor modulates atrial natriuretic peptide signaling.

Authors:  Michael Hartmann; Boris V Skryabin; Thomas Müller; Alexandra Gazinski; Juliane Schröter; Birgit Gassner; Viacheslav O Nikolaev; Moritz Bünemann; Michaela Kuhn
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

10.  Discovering a new role for the atrial natriuretic peptide: A novel risk factor for cardiovascular diseases.

Authors:  Speranza Rubattu; Massimo Volpe
Journal:  Heart Int       Date:  2006-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.